Inventor

WANG SHAOMENG

US85 patents

⚠️ This page may combine multiple inventors who share the name “WANG SHAOMENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WANG SHAOMENG

UNIV MICHIGAN REGENTS

Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

N-(phenylsulfonyl)benzamides and related compounds as BCL-2 inhibitors

9H-pyrimido [4,5-B] indoles as BET bromodomain inhibitors

BET bromodomain inhibitors and therapeutic methods using the same

9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitors

BET bromodomain inhibitors and therapeutic methods using the same

9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors

N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors

MDM2 inhibitors and therapeutic methods using the same

Small molecule MDM2 protein degraders

Monofunctional intermediates for ligand-dependent target protein degradation

Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitors

N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors

Aminopyrimidines as ALK inhibitors

WANG SHAOMENG

Small molecule inhibitors of MDM2 and the uses thereof

Small molecule inhibitors of MDM2 and the uses thereof

Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

Spiro-oxindole MDM2 antagonists

Spiro-oxindole MDM2 antagonists

Spiro-oxindole MDM2 antagonists

Heteroaryl-substituted bicyclic Smac mimetics and the uses thereof

Diazo bicyclic Smac mimetics and the uses thereof

Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof

Bivalent diazo bicyclic Smac mimetics and the uses thereof

Bivalent SMAC mimetics and the uses thereof

Process for the preparation of small molecule inhibitors of MDM2 and intermediates used therein

Small molecule antagonists of Bcl-2 family proteins

Small molecule inhibitors of MDM2 and the uses thereof

UNIV MICHIGAN

Small molecule inhibitors of MDM2 and the uses thereof

Indole inhibitors of MDM2 and the uses thereof

BCL-2/BCL-XL inhibitors and therapeutic methods using the same

Small molecule antagonists of Bcl-2 family proteins

Small molecule inhibitors targeted at Bcl-2

Gossypol co-crystals and the use thereof

Conformationally constrained Smac mimetics and the uses thereof

Bivalent Smac mimetics and the uses thereof

Conformationally constrained Smac mimetics and the uses thereof

Bivalent inhibitors of IAP proteins and therapeutic methods using the same

Spiro-oxindole MDM2 antagonists

UNIV GEORGETOWN

Substituted 2-pyrrolidinone activators of PKC

Substituted 2-pyrrolidinone activators of PKC

GEORGETOWN UNIVERSITY SCHOOL O

Matriptase, a serine protease and its applications

Structure based discovery of inhibitors of matriptase for the treatment of cancer and other conditions

UNIV GEORGETOWN MED CENTER

Small molecule inhibitors targeted at Bcl-2

ADHEREX TECHNOLOGIES INC

Peptidomimetic modulators of cell adhesion

ALIBABA GROUP HOLDING LTD

Method and apparatus for training model based on random forest

ASCENTAGE PHARMA SUZHOU CO LTD

Macrocyclic indoles as Mcl-1 inhibitors

US HEALTH

Conformationally constrained diacylglycerol analogues

JIANGSU ASCENTAGE BIOMED DEV INC

Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors

UNIV MACHIGAN

Spiro-oxindole MDM2 antagonists